# Coronavirus Response - Active Support for Hospitalised Covid-19 Patients

> **NCT04343001** · PHASE3 · WITHDRAWN · sponsor: **London School of Hygiene and Tropical Medicine**

## Conditions studied

- Covid-19

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Losartan
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT04343001
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-10
- **Primary completion:** 2021-04
- **Final completion:** 2021-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Grant not obtained
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04343001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04343001, "Coronavirus Response - Active Support for Hospitalised Covid-19 Patients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04343001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*